“…In terms of question (2), several antivirals, including rituximab, have been used for a number of conditions; for example, cases of uveitis (valganciclovir),47 interstitial pneumonitis with pancytopenia (acyclovir),48 cutaneous amyloidosis (acyclovir),49 vasculitis (eg, of CNS and or eye—acyclovir),50 51 keratoconjunctivitis (acyclovir),52 interstitial nephritis (acyclovir),53 erythema multiforme (acyclovir),54 acute retinal necrosis (acyclovir),55 transverse myelitis (ganciclovir),56 oesophagitis (acyclovir),57 epithelial cell tumours and haematological malignancies(ganciclovir),58 59 other malignancies (cidofovir)60 and other blood dyscrasias (ganciclovir) 61. A 2010 review reported favourable outcomes of antiviral treatment in most immunocompetent patients with severe manifestations (mainly neurological: meningoencephalitis, cerebellitis, Guillain-Barre, facial nerve palsy, myeloradiculitis) in which antivirals had been used (mainly acyclovir, along with steroids) 62.…”